Summary
In the past one has been able to affect the autonomic nervous system to a varying degree in most respects except in depression of the sympathetic or adrenergic nervous system ; but the latter is now becoming a reality in certain respects. The problem of applying adrenergic blockade has been attacked and encouraging results have been obtained so that the medical profession can now treat the varied syndrome of sympathetic predominance. Vasospastic conditions of the vascular tree, including neurogenic or essential hypertension, are peculiarly susceptible in many instances to adrenergic blockade, and it behooves the medical profession to become more aware of the role of sympatholytics and the newer suppressants of sympathetic overflow.
Similar content being viewed by others
References
Berry. R. L.. Campbell. K. N.. Lvons. R. L., Moe. G. K. and Sutler. M. R.: The Use of Tetraethvlammouium in Peripheral Vascular Diseases and Causalgic Studies. Surgery, 20: 525, 1946.
Fellows. E. J., Macko. E., McLean, R. A., Kerwin, J. F., Hall. G.. Milnes, F. J. and Ullvot. G. E.: A Comparison of the Oral and Intravenous Adrenergic Blocking Activitv of a Number of Beta-bromo and Chloro-alkylamines. Jl. Pharm. & Exp. Ther. 101: 11. Jan. 1951.
Rothlin. E.: The Pharmacology of the Natural and Dihvdrogenated Alkaloids of Ergot. Bull. Acad. Suisse. Se. Med. 2: 1. 1946/47.
Grimson. K. S., Reardon, M. J. Marzoni, F. A. and Herrix. J. P.: The Effects of Priscol (2-benzyl-4. 5-imidazoliue HCI) on Peripheral Vascular Diseases. Hypertension and Circulation in Patients. Ann. Surg, 127: 968. 1948. Rogers, M. P.: Use of Sympatholvtie Dvuer (Priscol) from the Point of View a General Surgicnl Practitioner. J. A. M. A. 140: 272, May 21, 1949.
Meier, R.. Yonkman. F. F.. Carver. B. N. and Gross, F.: A New Imidazoline Derivative with Marked Adrenolvtic Properties. Proc. Soc. Exper. Biol. & Med. 71: 70, 1949.
Gross, F., Druey, J. and Meier. R.: A New Group of Depressor Substances with a Special Type of Effect. Experentia 6: 19, 1950. Freis, E. D. and Fiunerty, F. A., Jr.: Suppression of Vasomotor Reflexes in Man Following l-Hydrazinophthalazine (C-5968). Proc. Soc. Exper. Biol. and Med. 75: 23, Oct., 1950.
Freis, E. D., Finnerty, Jr., F. A., and Walsh, W. B.: The Treatment of Severe Essential Hypertension. Medical Clinics of North America, 34: 1741, November, 1950. Yonkman, F. F., and Freis, E. D.: Rational Elimination of Side Reactions and/or Tolerance in the Development of Potentially Valuable Drugs. Aniology, 3:36, Feb. 1952.
Schroeder, H. A.: Effects of Hypertension of Sulfhydryl and Hydrazine Compounds. Jl. Clin. Inves. June, 1951.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rogers, M.P., Yonkman, F.F. Adrenergic blocking agents: Their use in clinical medicine. Amer. Jour. Dig. Dis. 19, 144–146 (1952). https://doi.org/10.1007/BF02893204
Issue Date:
DOI: https://doi.org/10.1007/BF02893204